These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 30518564)
1. Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states. Lake EW; Muretta JM; Thompson AR; Rasmussen DM; Majumdar A; Faber EB; Ruff EF; Thomas DD; Levinson NM Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11894-E11903. PubMed ID: 30518564 [TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule inhibitors of the Aurora-A/TPX2 complex. Asteriti IA; Daidone F; Colotti G; Rinaldo S; Lavia P; Guarguaglini G; Paiardini A Oncotarget; 2017 May; 8(19):32117-32133. PubMed ID: 28389630 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2. Zorba A; Buosi V; Kutter S; Kern N; Pontiggia F; Cho YJ; Kern D Elife; 2014 May; 3():e02667. PubMed ID: 24867643 [TBL] [Abstract][Full Text] [Related]
4. A TPX2 Proteomimetic Has Enhanced Affinity for Aurora-A Due to Hydrocarbon Stapling of a Helix. Rennie YK; McIntyre PJ; Akindele T; Bayliss R; Jamieson AG ACS Chem Biol; 2016 Dec; 11(12):3383-3390. PubMed ID: 27775325 [TBL] [Abstract][Full Text] [Related]
5. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors. Vijayan RS; He P; Modi V; Duong-Ly KC; Ma H; Peterson JR; Dunbrack RL; Levy RM J Med Chem; 2015 Jan; 58(1):466-79. PubMed ID: 25478866 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of human protein kinase Aurora A linked to drug selectivity. Pitsawong W; Buosi V; Otten R; Agafonov RV; Zorba A; Kern N; Kutter S; Kern G; Pádua RA; Meniche X; Kern D Elife; 2018 Jun; 7():. PubMed ID: 29901437 [TBL] [Abstract][Full Text] [Related]
7. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines? Panicker RC; Coyne AG; Srinivasan R Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768 [TBL] [Abstract][Full Text] [Related]
8. Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single-Molecule Spectroscopy. Gilburt JAH; Sarkar H; Sheldrake P; Blagg J; Ying L; Dodson CA Angew Chem Int Ed Engl; 2017 Sep; 56(38):11409-11414. PubMed ID: 28700101 [TBL] [Abstract][Full Text] [Related]
9. A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation. Ruff EF; Muretta JM; Thompson AR; Lake EW; Cyphers S; Albanese SK; Hanson SM; Behr JM; Thomas DD; Chodera JD; Levinson NM Elife; 2018 Feb; 7():. PubMed ID: 29465396 [TBL] [Abstract][Full Text] [Related]
10. Switching Aurora-A kinase on and off at an allosteric site. Bayliss R; Burgess SG; McIntyre PJ FEBS J; 2017 Sep; 284(18):2947-2954. PubMed ID: 28342286 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation, Mg-ADP, and Inhibitors Differentially Shape the Conformational Dynamics of the A-Loop of Aurora-A. Musavizadeh Z; Grottesi A; Guarguaglini G; Paiardini A Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921540 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches. McIntyre PJ; Collins PM; Vrzal L; Birchall K; Arnold LH; Mpamhanga C; Coombs PJ; Burgess SG; Richards MW; Winter A; Veverka V; Delft FV; Merritt A; Bayliss R ACS Chem Biol; 2017 Nov; 12(11):2906-2914. PubMed ID: 29045126 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic drug selectivity between wild-type and mutant BRaf kinases in colon cancer. Zhang J; Ji T J Mol Model; 2017 Jan; 23(1):1. PubMed ID: 27921184 [TBL] [Abstract][Full Text] [Related]
15. Structural Characterization of the Aurora Kinase B "DFG-flip" Using Metadynamics. Lakkaniga NR; Balasubramaniam M; Zhang S; Frett B; Li HY AAPS J; 2019 Dec; 22(1):14. PubMed ID: 31853739 [TBL] [Abstract][Full Text] [Related]
16. Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis. Gupta A; Jain R; Wahi D; Goyal S; Jamal S; Grover A J Recept Signal Transduct Res; 2015; 35(6):626-33. PubMed ID: 26390942 [TBL] [Abstract][Full Text] [Related]
17. A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A. Martin MP; Zhu JY; Lawrence HR; Pireddu R; Luo Y; Alam R; Ozcan S; Sebti SM; Lawrence NJ; Schönbrunn E ACS Chem Biol; 2012 Apr; 7(4):698-706. PubMed ID: 22248356 [TBL] [Abstract][Full Text] [Related]
18. Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction. Cole DJ; Janecek M; Stokes JE; Rossmann M; Faver JC; McKenzie GJ; Venkitaraman AR; Hyvönen M; Spring DR; Huggins DJ; Jorgensen WL Chem Commun (Camb); 2017 Aug; 53(67):9372-9375. PubMed ID: 28787041 [TBL] [Abstract][Full Text] [Related]
19. Quantitative Lysine Reactivity Profiling Reveals Conformational Inhibition Dynamics and Potency of Aurora A Kinase Inhibitors. Chen J; Wang A; Liu B; Zhou Y; Luo P; Zhang Z; Li G; Liu Q; Wang F Anal Chem; 2019 Oct; 91(20):13222-13229. PubMed ID: 31525957 [TBL] [Abstract][Full Text] [Related]
20. Modeling conformational flexibility of kinases in inactive states. Schwarz D; Merget B; Deane C; Fulle S Proteins; 2019 Nov; 87(11):943-951. PubMed ID: 31168936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]